Sandra Calvin - Net Worth and Insider Trading
Sandra Calvin Net Worth
The estimated net worth of Sandra Calvin is at least $993,629 dollars as of 2025-01-12. Sandra Calvin is the SVP, CHIEF ACCOUNTING OFFICER of Travere Therapeutics Inc and owns about 54,927 shares of Travere Therapeutics Inc (TVTX) stock worth over $993,629. Details can be seen in Sandra Calvin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sandra Calvin has not made any transactions after 2024-12-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sandra Calvin
Sandra Calvin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sandra Calvin owns 1 companies in total, including Travere Therapeutics Inc (TVTX) .
Click here to see the complete history of Sandra Calvin’s form 4 insider trades.
Insider Ownership Summary of Sandra Calvin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2024-12-26 | VP & Corp Controller and CAO |
Sandra Calvin Latest Holdings Summary
Sandra Calvin currently owns a total of 1 stock. Sandra Calvin owns 54,927 shares of Travere Therapeutics Inc (TVTX) as of December 26, 2024, with a value of $993,629.
Latest Holdings of Sandra Calvin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2024-12-26 | 54,927 | 18.09 | 993,629 |
Holding Weightings of Sandra Calvin
Sandra Calvin Form 4 Trading Tracker
According to the SEC Form 4 filings, Sandra Calvin has made a total of 10 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Travere Therapeutics Inc is the sale of 15,000 shares on December 26, 2024, which brought Sandra Calvin around $258,300.
Insider Trading History of Sandra Calvin
- 1
Sandra Calvin Trading Performance
Sandra Calvin Ownership Network
Ownership Network List of Sandra Calvin
Ownership Network Relation of Sandra Calvin
Sandra Calvin Owned Company Details
What does Travere Therapeutics Inc do?
Who are the key executives at Travere Therapeutics Inc?
Sandra Calvin is the VP & Corp Controller and CAO of Travere Therapeutics Inc. Other key executives at Travere Therapeutics Inc include Chief Medical Officer Jula Inrig , Senior Vice President & R&D William E. Rote , and Chief Financial Officer Christopher R. Cline .
Travere Therapeutics Inc (TVTX) Insider Trades Summary
Over the past 18 months, Sandra Calvin made 3 insider transaction in Travere Therapeutics Inc (TVTX) with a net sale of 28,000. Other recent insider transactions involving Travere Therapeutics Inc (TVTX) include a net sale of 4,368 shares made by Christopher R. Cline , a net sale of 7,890 shares made by Jula Inrig , and a net sale of 33,453 shares made by Eric M Dube .
In summary, during the past 3 months, insiders sold 29,596 shares of Travere Therapeutics Inc (TVTX) in total and bought 0 shares, with a net sale of 29,596 shares. During the past 18 months, 177,080 shares of Travere Therapeutics Inc (TVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 177,080 shares.
Travere Therapeutics Inc (TVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Travere Therapeutics Inc Insider Transactions
Sandra Calvin Mailing Address
Above is the net worth, insider trading, and ownership report for Sandra Calvin. You might contact Sandra Calvin via mailing address: 3611 Valley Center Drive, Suite 300, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
